Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 2Phase 1/2 1Phase 1 1

Status

Completed 6Terminated 3Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 2Breast 1

Conditions

Neoplasm Metastasis 2Brain Neoplasms 2Breast Neoplasms 1

Interventions

Cyclophosphamide 166Docetaxel 154Bevacizumab 153Carboplatin 148Gemcitabine 146Cisplatin 146pembrolizumab 144Radiotherapy 135Paclitaxel 132Capecitabine 122Rituximab 115Oxaliplatin 104Fluorouracil 103Nivolumab 94Irinotecan 85Doxorubicin 85Pemetrexed 83Leucovorin 82Dexamethasone 82fludarabine 74fludarabine phosphate 72Bortezomib 69Etoposide 67Erlotinib Hydrochloride 66Cetuximab 65Methotrexate 58Trastuzumab 56Cytarabine 54Lenalidomide 50Everolimus 49

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Terminated × Mental Status and Dementia Tests × Clear all
NCT02774681 2020-04-14

Palbociclib in Treating Patients With Metastatic HER-2 Positive Breast Cancer With Brain Metastasis

Northwestern University

Phase 2 Terminated
12 enrolled 11 charts
Breast

Breast Neoplasms

NCT00814463 2019-02-26

Stereotactic Radiosurgery After Surgery in Treating Patients With Brain Metastases

Duke University

Phase 2 Terminated
1 enrolled 6 charts
CNS

Brain Neoplasms, Neoplasm Metastasis

NCT00910039 2014-09-29

Sunitinib Malate After Stereotactic Radiosurgery in Treating Patients With Newly Diagnosed Brain Metastases

Case Comprehensive Cancer Center

Phase 2 Terminated
14 enrolled 12 charts
CNS

Brain Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡